Medigene AG
MDGEFOTCHealthcare● Active
$2.59
+$0.00(+0.00%)
Market Cap$38170366
P/E Ratio—
52W High$2.59
52W Low$0.1
Medigene AG (MDGEF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDGEF · earnings · updated Jun 15, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 15, 2024EPS Actual
-$0.16
Est. -$0.60 · +73.1%
Revenue
$0.00B
Est. $0.00B · -64.8%
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 15, 2024
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 3-Quarter EPS Beat Streak
MDGEF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
79
days
Expected Date
Sep 2, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away79
Expected DateSep 2, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.79 | — | — | — | $0.00B | — |
| ◌ Q3 FY2025 | Jul 31, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | Apr 28, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 28, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Oct 24, 2024 | — | — | — | — | — | — |
| ▲ Q3 FY2024 | Aug 15, 2024 | -$0.60 | -$0.16 | +73.1% | $0.00B | $0.00B | -64.8% |
| ◌ Q2 FY2024 | Apr 26, 2024 | — | — | — | — | — | — |
| ▲ Q1 FY2024 | Mar 28, 2024 | -$1.07 | -$0.21 | +80.7% | $0.00B | $0.00B | -46.0% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.79
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 31, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 28, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Oct 24, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 15, 2024Beat
EPS Actual
-$0.16
EPS Est.
-$0.60
EPS Surpr.
+73.1%
Revenue
$0.00B
Q2 FY2024
Apr 26, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 28, 2024Beat
EPS Actual
-$0.21
EPS Est.
-$1.07
EPS Surpr.
+80.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Q3 FY2027 | $-0.52 | $-0.52 | $-0.52 | 1 |
| Q2 FY2027 | $-0.93 | $-0.93 | $-0.93 | 1 |
| Q1 FY2027 | $-0.34 | $-0.34 | $-0.34 | 1 |
| Q4 FY2026 | $-0.34 | $-0.34 | $-0.34 | 1 |
| Q3 FY2026 | $-0.93 | $-0.93 | $-0.93 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2024 | Aug 15, 2024 | +73.1% | $2.19 | $2.19 | +0.00% |
| ▲ Q1 FY2024 | Mar 28, 2024 | +80.7% | $5.08 | $4.86 | -4.33% |
| — Q1 FY2024 | Jan 8, 2024 | — | $2.76 | $2.76 | +0.00% |
| — Q3 FY2023 | Aug 17, 2023 | — | $3.68 | $3.68 | +0.00% |
| ▲ Q2 FY2023 | Jun 30, 2023 | +77.1% | $3.89 | $3.89 | +0.00% |
| — Q1 FY2023 | Mar 29, 2023 | — | $3.87 | $4.20 | +8.53% |
Q3 FY2024+0.00%
Report Date
Aug 15, 2024
EPS Beat/Miss
+73.1%
Price Before
$2.19
Price After
$2.19
Q1 FY2024-4.33%
Report Date
Mar 28, 2024
EPS Beat/Miss
+80.7%
Price Before
$5.08
Price After
$4.86
Q1 FY2024+0.00%
Report Date
Jan 8, 2024
EPS Beat/Miss
—
Price Before
$2.76
Price After
$2.76
Q3 FY2023+0.00%
Report Date
Aug 17, 2023
EPS Beat/Miss
—
Price Before
$3.68
Price After
$3.68
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
+77.1%
Price Before
$3.89
Price After
$3.89
Q1 FY2023+8.53%
Report Date
Mar 29, 2023
EPS Beat/Miss
—
Price Before
$3.87
Price After
$4.20
Avg Beat Reaction-1.44%
Beat Rate3 / 6 quarters
Largest Move+8.53% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDGEF ends December
Medigene AG (MDGEF) most recently reported earnings on August 15, 2024 for Q3 FY2024, posting EPS of $-0.16 — beating the analyst consensus of $-0.60 by +73.1%. MDGEF has beaten EPS estimates for 3 consecutive quarters. The next MDGEF earnings date is expected around September 2, 2026.
Each quarter, investors track MDGEF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDGEF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDGEF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDGEF earnings · 5 questionsMedigene AG's next earnings report is expected around September 2, 2026. MDGEF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDGEF historically reports after market close (AMC).
MDGEF earnings datewhen is MDGEF earningsMDGEF next earnings datewhen does MDGEF report earningsMDGEF earnings calendar
▸ Source: FMP · Medigene AG SEC filings · US GAAP · Medigene AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026